PAM
ALBO

Panagora Asset Management’s Albireo Pharma Inc ALBO Stock Holding History

Panagora Asset Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,620
Closed -$64K – 2464
2016
Q4 		$64K Sell
3,620
-2
-0.1% -$42 ﹤0.01% 2050
2016
Q3 		$47K Buy
+3,622
New +$42.7K ﹤0.01% 2123

Other funds holding ALBO

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

Panagora Asset Management's ALBO Position: Q1 2017 in Review

Panagora Asset Management sold out of Albireo Pharma Inc (ALBO) in Q1 2017, closing a stake of 3,620 shares — an estimated $64K sold.

Panagora Asset Management first reported a position in ALBO in Q3 2016 and held it in 2 quarters. The position peaked at $64K in Q4 2016. 17 funds tracked by Wall St. Rank hold ALBO as of Q1 2017.

  • Panagora Asset Management reported no remaining Albireo Pharma Inc position as of Q1 2017 after selling out during the quarter.
  • Panagora Asset Management sold 3,620 Albireo Pharma Inc shares in Q1 2017, an estimated $64K.
  • Panagora Asset Management first reported a position in Albireo Pharma Inc in Q3 2016 and held it in 2 quarters.
  • Panagora Asset Management's Albireo Pharma Inc position peaked at $64K in Q4 2016.
  • 17 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2017.

Based on Panagora Asset Management's 13F filing for Q1 2017, filed 15 May 2017.